Is Pfizer Inc. overvalued?

Pfizer Inc. (PFE) looks fairly valued — trading about 3% below its fair value.

Fairly valued

Price

$24.29

Fair value

$25.05

Current P/E

17.9

Normal P/E

18.4

Market cap

$138.41B

Dividend yield

6.9%

Return on equity

9.0%

Sector

Healthcare

Fair value compares PFE's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 28 Jun 2026.

Related stocks